SCHEDULE 13D/A: Dr. Phillip Frost's Trust Increases Stake in Nocopi Technologies to 13.6%

Frost Gamma Investments Trust, controlled by Dr. Phillip Frost, has increased its beneficial ownership in Nocopi Technologies Inc. to 13.6% after acquiring an additional 195,852 common shares.

Summary

• Phillip Frost, M.D., and Frost Gamma Investments Trust (FGIT) have filed an Amendment No. 1 to their Schedule 13D regarding their beneficial ownership in NOCOPI TECHNOLOGIES INC/MD/.
• The filing reports that FGIT now holds 1,467,782 Common Shares, representing approximately 13.6% of the Issuer's 10,792,913 outstanding Common Shares.
• This updated ownership is based on the Issuer's Form 10-Q filed on May 13, 2025.
• The amendment was triggered by FGIT's acquisition of an additional 195,852 Common Shares on June 6, 2025.
• These shares were purchased at a price of $1.10 per share from a non-affiliate shareholder in a private secondary transaction.
• The Reporting Persons state that the shares were acquired for investment purposes and they currently have no plans for extraordinary corporate transactions involving Nocopi Technologies.

Sentiment

Score: 7

Explanation: The increased stake by a significant investor like Dr. Phillip Frost, explicitly for 'investment purposes' and without immediate plans for corporate changes, generally signals confidence in the company's long-term prospects. This is a positive signal for existing and potential shareholders.

Positives

• A significant investor, Dr. Phillip Frost, through Frost Gamma Investments Trust, has increased their stake in Nocopi Technologies, indicating continued confidence in the company.
• The acquisition of an additional 195,852 common shares demonstrates a commitment to their investment.
• The stated purpose of the acquisition is 'for investment purposes,' suggesting a long-term view.

Future Outlook

The Reporting Persons state that the Common Shares were acquired for investment purposes and they do not currently have any plans or proposals regarding extraordinary corporate transactions involving Nocopi Technologies Inc., including those typically described in Item 4 of Schedule 13D.

Management Comments

• "The Common Shares were acquired for investment purposes."
• "The Reporting Persons do not have any plans or proposals with respect to any extraordinary corporate transaction involving the Issuer."

Industry Context

This filing is a standard disclosure of a change in beneficial ownership by a significant shareholder. It does not provide information on broader industry trends or Nocopi Technologies' competitive position within its industry.

Related Party Transactions

• The acquisition of 195,852 Common Shares was from a 'non-affiliate shareholder.'

Stakeholder Impact

• Shareholders: The increased stake by a prominent investor like Dr. Phillip Frost may be viewed positively, potentially signaling confidence in the company's value and future.
• Company Management: The statement that the shares were acquired for investment purposes and without plans for extraordinary corporate transactions suggests stability regarding the current management and strategic direction from this particular investor's perspective.

Next Steps

• The Reporting Persons intend to hold the shares for investment purposes.
• Future filings may occur if there are further significant changes in beneficial ownership or investment intent.

Key Dates

Keywords

NOCOPI TECHNOLOGIES INC, Phillip Frost, Frost Gamma Investments Trust, Schedule 13D, Beneficial Ownership, Common Shares, Investment, SEC Filing, Share Acquisition, Private Transaction